Enhancing chimeric antigen receptor T cell therapy by modulating the p53 signaling network with Δ133p53α.
Roselle C, Horikawa I, Chen L, Kelly AR, Gonzales D, Da T, Wellhausen N, Rommel PC, Baker D, Suhoski M, Scholler J, O'Connor RS, Young RM, Harris CC, June CH.
Roselle C, et al. Among authors: horikawa i.
Proc Natl Acad Sci U S A. 2024 Mar 5;121(10):e2317735121. doi: 10.1073/pnas.2317735121. Epub 2024 Feb 26.
Proc Natl Acad Sci U S A. 2024.
PMID: 38408246
Free PMC article.